Evidence map›Paper›PMID 42798512›Full record

ArticleFrontiers in neurology2026

Evaluating migraine tracking methods: a study of headache diary use in Lithuania.

David Petrosian, Mantas Jokubaitis, Kristina Ryliškienė

Abstract read
In one paragraph

Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David PetrosianFaculty of Medicine, Vilnius University, Institute of Clinical Medicine, Clinic of Neurology and Neurosurgery, Vilnius, Lithuania.
Mantas JokubaitisDepartment of Nervous Diseases, Vilnius City Clinical Hospital, Vilnius, Lithuania.
Kristina RyliškienėFaculty of Medicine, Vilnius University, Institute of Clinical Medicine, Clinic of Neurology and Neurosurgery, Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Migraine management is essential for improving patient wellbeing. Headache diaries support active self-management and provide valuable clinical data to healthcare professionals. This study evaluated diary use, recording methods, and utilization patterns in Lithuania. Methods: In 2022-2023 an anonymous online survey was distributed nationwide through migraine support groups in social networks, online migraine self-help platforms, and the Lithuanian Association of Migraine Patients' website. Our questionnaire included sociodemographic, migraine-related, headache tracking methods, and previous experience with telemedicine. Results: A total of 847 patients were included in the study, with a median age of 35 years (IQR: 30-43); 823 (97.2%) participants were female. 345 (40.7%) patients reported using a headache diary, with 203 (58.8%) using paper-based, 167 (48.4%) electronic diaries, and 27 (7.8%) using both. Adherence to headache diaries was higher among chronic migraine patients compared to episodic migraine (76.3% vs. 38.1%, Conclusions: This study provides insights into the preferences of Lithuanian migraine patients for tracking attack-related information. Younger patients and those with episodic migraine were more likely to use digital tools, while prior telemedicine experience was associated with headache diary use. These findings highlight how digital tools could be useful in managing migraines, while also showing that traditional paper-based approaches still have a place.

Indexed as

Diaries as TopicMigraine DisordersAdultFemaleHumansLithuaniaMaleMiddle AgedSurveys and QuestionnairesTelemedicinediariesheadachemigrainetelehealthtelemedicine

Identifiers

PMID42798512
PMCPMC13612321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.